144 related articles for article (PubMed ID: 22197085)
1. Pathologic validation of a model based on diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging for tumor delineation in the prostate peripheral zone.
Groenendaal G; Borren A; Moman MR; Monninkhof E; van Diest PJ; Philippens ME; van Vulpen M; van der Heide UA
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e537-44. PubMed ID: 22197085
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric MRI Tumor Probability Model for the Detection of Locally Recurrent Prostate Cancer After Radiation Therapy: Pathologic Validation and Comparison With Manual Tumor Delineations.
Dinis Fernandes C; Simões R; Ghobadi G; Heijmink SWTPJ; Schoots IG; de Jong J; Walraven I; van der Poel HG; van Houdt PJ; Smolic M; Pos FJ; van der Heide UA
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):140-148. PubMed ID: 31085288
[TBL] [Abstract][Full Text] [Related]
3. Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and Gleason score to predict positive surgical margins.
Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
Urology; 2004 Sep; 64(3):516-21. PubMed ID: 15351582
[TBL] [Abstract][Full Text] [Related]
4. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
6. Validation of functional imaging with pathology for tumor delineation in the prostate.
Groenendaal G; Moman MR; Korporaal JG; van Diest PJ; van Vulpen M; Philippens ME; van der Heide UA
Radiother Oncol; 2010 Feb; 94(2):145-50. PubMed ID: 20116116
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI.
Langer DL; van der Kwast TH; Evans AJ; Trachtenberg J; Wilson BC; Haider MA
J Magn Reson Imaging; 2009 Aug; 30(2):327-34. PubMed ID: 19629981
[TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.
Haider MA; Chung P; Sweet J; Toi A; Jhaveri K; Ménard C; Warde P; Trachtenberg J; Lockwood G; Milosevic M
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):425-30. PubMed ID: 17881141
[TBL] [Abstract][Full Text] [Related]
9. Automatic segmentation of pelvic structures from magnetic resonance images for prostate cancer radiotherapy.
Pasquier D; Lacornerie T; Vermandel M; Rousseau J; Lartigau E; Betrouni N
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):592-600. PubMed ID: 17498571
[TBL] [Abstract][Full Text] [Related]
10. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.
Sciarra A; Panebianco V; Salciccia S; Osimani M; Lisi D; Ciccariello M; Passariello R; Di Silverio F; Gentile V
Eur Urol; 2008 Sep; 54(3):589-600. PubMed ID: 18226441
[TBL] [Abstract][Full Text] [Related]
11. Focal salvage guided by T2-weighted and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer recurrences.
Moman MR; van den Berg CA; Boeken Kruger AE; Battermann JJ; Moerland MA; van der Heide UA; van Vulpen M
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):741-6. PubMed ID: 19804948
[TBL] [Abstract][Full Text] [Related]
12. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings.
Villers A; Puech P; Mouton D; Leroy X; Ballereau C; Lemaitre L
J Urol; 2006 Dec; 176(6 Pt 1):2432-7. PubMed ID: 17085122
[TBL] [Abstract][Full Text] [Related]
13. Computer-assisted analysis of peripheral zone prostate lesions using T2-weighted and dynamic contrast enhanced T1-weighted MRI.
Vos PC; Hambrock T; Barenstz JO; Huisman HJ
Phys Med Biol; 2010 Mar; 55(6):1719-34. PubMed ID: 20197602
[TBL] [Abstract][Full Text] [Related]
14. Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and gleason score for predicting prostate cancer biochemical recurrence after radical prostatectomy.
Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
Urology; 2004 Dec; 64(6):1165-70. PubMed ID: 15596191
[TBL] [Abstract][Full Text] [Related]
15. MR-guided prostate biopsy for planning of focal salvage after radiation therapy.
Ménard C; Iupati D; Publicover J; Lee J; Abed J; O'Leary G; Simeonov A; Foltz WD; Milosevic M; Catton C; Morton G; Bristow R; Bayley A; Atenafu EG; Evans AJ; Jaffray DA; Chung P; Brock KK; Haider MA
Radiology; 2015 Jan; 274(1):181-91. PubMed ID: 25203127
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous MRI diffusion and perfusion imaging for tumor delineation in prostate cancer patients.
Groenendaal G; van den Berg CA; Korporaal JG; Philippens ME; Luijten PR; van Vulpen M; van der Heide UA
Radiother Oncol; 2010 May; 95(2):185-90. PubMed ID: 20231041
[TBL] [Abstract][Full Text] [Related]
17. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer.
Hambrock T; Somford DM; Huisman HJ; van Oort IM; Witjes JA; Hulsbergen-van de Kaa CA; Scheenen T; Barentsz JO
Radiology; 2011 May; 259(2):453-61. PubMed ID: 21502392
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted magnetic resonance imaging in patients with unilateral prostate cancer on extended prostate biopsy: predictive accuracy of laterality and implications for hemi-ablative therapy.
Jeong IG; Kim JK; Cho KS; You D; Song C; Hong JH; Ahn H; Kim CS
J Urol; 2010 Nov; 184(5):1963-9. PubMed ID: 20851437
[TBL] [Abstract][Full Text] [Related]
19. Description of magnetic resonance imaging-derived enhancement variables in pathologically confirmed prostate cancer and normal peripheral zone regions.
Zelhof B; Lowry M; Rodrigues G; Kraus S; Turnbull L
BJU Int; 2009 Sep; 104(5):621-7. PubMed ID: 19281464
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging.
Tanimoto A; Nakashima J; Kohno H; Shinmoto H; Kuribayashi S
J Magn Reson Imaging; 2007 Jan; 25(1):146-52. PubMed ID: 17139633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
